155 related articles for article (PubMed ID: 33551721)
21. Diffusion Basis Spectrum and Diffusion Tensor Imaging Detect Hippocampal Inflammation and Dendritic Injury in a Virus-Induced Mouse Model of Epilepsy.
Zhan J; Lin TH; Libbey JE; Sun P; Ye Z; Song C; Wallendorf M; Gong H; Fujinami RS; Song SK
Front Neurosci; 2018; 12():77. PubMed ID: 29497358
[TBL] [Abstract][Full Text] [Related]
22. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
[TBL] [Abstract][Full Text] [Related]
23. Diffusion basis spectrum imaging provides insights into MS pathology.
Sun P; George A; Perantie DC; Trinkaus K; Ye Z; Naismith RT; Song SK; Cross AH
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31871296
[TBL] [Abstract][Full Text] [Related]
24. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
25. Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve.
Gresle MM; Liu Y; Kilpatrick TJ; Kemper D; Wu QZ; Hu B; Fu QL; So KF; Sheng G; Huang G; Pepinsky B; Butzkueven H; Mi S
Mult Scler J Exp Transl Clin; 2016; 2():2055217316641704. PubMed ID: 28607723
[TBL] [Abstract][Full Text] [Related]
26. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
[TBL] [Abstract][Full Text] [Related]
27. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
[TBL] [Abstract][Full Text] [Related]
28. Optic neuritis.
Dooley MC; Foroozan R
J Ophthalmic Vis Res; 2010 Jul; 5(3):182-7. PubMed ID: 22737354
[TBL] [Abstract][Full Text] [Related]
29. Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial.
De Lott LB; Burke JF; Andrews CA; Costello F; Cornblath WT; Trobe JD; Lee PP; Kerber KA
JAMA Netw Open; 2020 May; 3(5):e204339. PubMed ID: 32379333
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Tur C; Goodkin O; Altmann DR; Jenkins TM; Miszkiel K; Mirigliani A; Fini C; Gandini Wheeler-Kingshott CA; Thompson AJ; Ciccarelli O; Toosy AT
Brain; 2016 Mar; 139(Pt 3):816-28. PubMed ID: 26912640
[TBL] [Abstract][Full Text] [Related]
31. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
32. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
Guan Y; Shindler KS; Tabuena P; Rostami AM
J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection for acute optic neuritis-Can it work?
Raftopoulos RE; Kapoor R
Mult Scler Relat Disord; 2013 Oct; 2(4):307-11. PubMed ID: 25877841
[TBL] [Abstract][Full Text] [Related]
34. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions.
Ye Z; George A; Wu AT; Niu X; Lin J; Adusumilli G; Naismith RT; Cross AH; Sun P; Song SK
Ann Clin Transl Neurol; 2020 May; 7(5):695-706. PubMed ID: 32304291
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis.
Khan RS; Dine K; Geisler JG; Shindler KS
Oxid Med Cell Longev; 2017; 2017():7180632. PubMed ID: 28680531
[TBL] [Abstract][Full Text] [Related]
36. Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Shen T; You Y; Arunachalam S; Fontes A; Liu S; Gupta V; Parratt J; Wang C; Barnett M; Barton J; Chitranshi N; Zhu L; Fraser CL; Graham SL; Klistorner A; Yiannikas C
Ophthalmology; 2019 Mar; 126(3):445-453. PubMed ID: 30060979
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic Treatment with Intravenous Immunoglobulin Attenuates Experimental Optic Neuritis in Mice.
Takahashi H; Okuda S; Tamura M; Kamei S; Aizawa R; Kobayashi T
Biol Pharm Bull; 2019; 42(2):173-178. PubMed ID: 30713249
[TBL] [Abstract][Full Text] [Related]
38. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
[TBL] [Abstract][Full Text] [Related]
39. Microfluorimetry defines early axonal damage in a rat model of optic neuritis: a novel method targeting early CNS autoimmunity.
Stokely ME; Bhat MA; Koulen P
J Neurosci Methods; 2007 Nov; 166(2):217-28. PubMed ID: 17719649
[TBL] [Abstract][Full Text] [Related]
40. Visual Outcomes and Clinical Manifestations of Pediatric Optic Neuritis in Indian Population: An Institutional Study.
Ambika S; Padmalakshmi K; Venkatraman V; Noronha OV
J Neuroophthalmol; 2018 Dec; 38(4):462-465. PubMed ID: 29554001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
